GLP-1 RA use linked to lower rates of hyperkalemia in type 2 diabetes
Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor (RASi) discontinuation compared with treatment with ...
Aug 13, 2024
0
5